Wetherby Asset Management Inc. decreased its position in Fresenius Medical Care Corporation (NYSE:FMS) by 0.5% during the second quarter, Holdings Channel reports. The firm owned 14,958 shares of the company’s stock after selling 70 shares during the period. Wetherby Asset Management Inc.’s holdings in Fresenius Medical Care Corporation were worth $723,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Quadrant Capital Group LLC boosted its position in shares of Fresenius Medical Care Corporation by 12.7% in the first quarter. Quadrant Capital Group LLC now owns 3,736 shares of the company’s stock worth $149,000 after buying an additional 420 shares during the period. Greenleaf Trust acquired a new position in shares of Fresenius Medical Care Corporation during the first quarter worth $205,000. RMB Capital Management LLC acquired a new position in shares of Fresenius Medical Care Corporation during the first quarter worth $220,000. Park Avenue Securities LLC acquired a new position in shares of Fresenius Medical Care Corporation during the second quarter worth $234,000. Finally, Moloney Securities Asset Management LLC acquired a new position in shares of Fresenius Medical Care Corporation during the second quarter worth $249,000. 2.84% of the stock is owned by institutional investors and hedge funds.

Shares of Fresenius Medical Care Corporation (NYSE FMS) opened at 45.85 on Friday. The stock has a market capitalization of $28.14 billion, a PE ratio of 20.02 and a beta of 0.47. The firm has a 50-day moving average of $47.66 and a 200 day moving average of $44.76. Fresenius Medical Care Corporation has a 1-year low of $38.05 and a 1-year high of $50.22.

Fresenius Medical Care Corporation (NYSE:FMS) last released its quarterly earnings results on Tuesday, August 1st. The company reported $0.48 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.53 by $0.05. Fresenius Medical Care Corporation had a net margin of 7.06% and a return on equity of 11.57%. The firm had revenue of $4.47 billion for the quarter, compared to analyst estimates of $5.20 billion. During the same quarter in the prior year, the firm earned $0.96 EPS. The firm’s revenue was up 11.1% compared to the same quarter last year. On average, equities analysts anticipate that Fresenius Medical Care Corporation will post $2.33 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Wetherby Asset Management Inc. Sells 70 Shares of Fresenius Medical Care Corporation (NYSE:FMS)” was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/wetherby-asset-management-inc-sells-70-shares-of-fresenius-medical-care-corporation-nysefms/1477439.html.

FMS has been the subject of a number of recent research reports. Zacks Investment Research raised shares of Fresenius Medical Care Corporation from a “hold” rating to a “buy” rating and set a $49.00 price objective for the company in a research note on Tuesday, April 25th. Nord/LB reissued a “buy” rating on shares of Fresenius Medical Care Corporation in a research note on Wednesday, June 28th. BidaskClub cut shares of Fresenius Medical Care Corporation from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. DZ Bank AG reissued a “buy” rating on shares of Fresenius Medical Care Corporation in a research note on Monday, August 7th. Finally, Royal Bank Of Canada reissued a “hold” rating and set a $44.00 price objective on shares of Fresenius Medical Care Corporation in a research note on Wednesday, July 5th. One analyst has rated the stock with a sell rating, four have given a hold rating and eight have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $48.67.

Fresenius Medical Care Corporation Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Want to see what other hedge funds are holding FMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fresenius Medical Care Corporation (NYSE:FMS).

Institutional Ownership by Quarter for Fresenius Medical Care Corporation (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.